AIV Logo AIV Assistant

Loading...

 Logo Vivos Therapeutics, Inc. - VVOS 6.74 USD

EPS
-4.99
P/B
21.25
ROE
-284.96
Beta
7.68
Target Price
6.30 USD

6.740 USD

6.740 USD

Daily: +0.00%
Key Metrics

EPS: -4.99

Book Value: 0.22

Price to Book: 21.25

Debt/Equity: 27.79

% Insiders: 1.513%

Growth

Revenue Growth: 0.19%

Estimates

Forward P/E: -3.33

Forward EPS: -0.55

Target Mean Price: 6.30

 Logo About Vivos Therapeutics, Inc. - (VVOS)

Country: United States

Sector: Health Care

Website: http://www.vivoslife.com

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Exchange Ticker
NMS (United States) VVOS

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Oct. 27, 2023 0.04
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion